F.-Y. Li et al.
Bioorganic&MedicinalChemistryxxx(xxxx)xxx–xxx
H, 3.60; N, 10.54; found: C, 49.76; H, 3.65; N, 10.59.
3H, CH3S), 2.64 (s, 3H, NHCH3), 2.17 (s, 3H, Ph-CH3). 13C NMR
(101 MHz, DMSO‑d6)
δ 167.36, 163.62, 163.39, 156.82, 142.80,
4.1.5. General synthetic procedure for If
140.58, 139.90, 138.68, 137.07, 135.28, 133.00, 132.81, 132.66,
132.43, 132.33, 132.12, 131.31, 126.50, 121.91, 107.91, 58.14, 38.85,
27.29, 18.83. Anal. calcd for C24H19Cl2F6N5O4S: C, 43.78; H, 2.91; N,
10.64; found: C, 43.83; H, 2.96; N, 10.68.
Compound Ie (0.28 g, 0.5 mmol) was dissolved in 10 mL anhydrous
tetrahydrofuran, and then m-CPBA (0.173 g, 1 mmol) was added to the
reaction at 0 °C. After 5 min, the solvent was evaporated and ethyl
acetate (15 mL) was added. The mixture was washed with saturated
sodium bicarbonate (15 mL) and saturated sodium chloride (15 mL)
successively, and dried with anhydrous sodium sulfate, and evaporated
to obtain If. White solid, yield: 92.7%, m.p. 211–212 °C. 1H NMR
(400 MHz, DMSO‑d6) δ 10.41 (s, 1H, Ph-NH-CO), 8.36 (d, J = 4.1 Hz,
1H, Ph-CO-NH), 7.90 (s, 1H, Ph-H), 7.69 (d, J = 8.1 Hz, 2H, 2Ph-H),
7.58 (d, J = 8.3 Hz, 1H, Pyrazole-H), 7.48 (s, 1H, Ph-H), 7.35 (s, 1H,
Ph-H), 4.61 (s, 2H, CH2SO2), 2.89 (s, 3H, CH3SO2), 2.65 (d, J = 3.9 Hz,
3H, NHCH3), 2.17 (s, 3H, Ph-CH3). 13C NMR (101 MHz, DMSO‑d6) δ
166.17, 155.65, 141.64, 139.42, 138.74, 137.26, 135.92, 133.47,
131.48, 130.92, 130.35, 129.92, 129.47, 128.80, 127.85, 125.37,
121.67, 106.64, 58.00, 29.60, 26.07, 17.64. Anal. calcd for
4.1.8. General synthetic procedure for Ii
Compound Ig (1.14 g, 2 mmol) and m-CPBA (0.519 g, 3 mmol) were
dissolved in 10 mL ethanol, and then a solution of potassium carbonate
(0.828 g, 6 mmol) in 5 mL water was added at 0 °C. The reaction was
stirred for 1 h at 0 °C. Ethyl acetate (25 mL) was added, then washed
with dilute hydrochloric acid (15 mL) and saturated sodium bicarbo-
nate solution (15 mL). The organic layer was dried and evaporated to
obtain Ii. White solid, yield: 83.1%, m.p. 163–164 °C. 1H NMR
(400 MHz, DMSO‑d6) δ 10.38 (s, 1H, Ph-NH-CO), 8.32 (d, J = 3.8 Hz,
1H, Ph-CO-NH), 7.81–7.72 (m, 3H, 2Ph-H and Pyrazole-H), 7.64 (d,
J = 8.1 Hz, 1H, Ph-H), 7.48 (s, 1H, Ph-H), 7.35 (s, 1H, Ph-H), 5.13 (s,
2H, CH2S), 3.33 (s, 3H, CH3S), 2.64 (d, J = 3.7 Hz, 3H, NHCH3), 2.17
(s, 3H, Ph-CH3). 13C NMR (101 MHz, DMSO‑d6) δ 166.37, 155.84,
142.32, 140.59, 138.92, 137.64, 136.08, 134.27, 131.89, 131.76,
131.63, 131.38, 131.14, 130.38, 127.17, 125.55, 121.00, 112.30,
106.90, 58.19, 38.78, 26.26, 17.81. Anal. calcd for C24H19Cl2F6N5O3S:
C, 44.87; H, 2.98; N, 10.90; found: C, 44.89; H, 2.99; N, 10.94.
C
22H19Cl2F3N4O4S: C, 46.90; H, 3.40; N, 9.94; found: C, 46.94; H, 3.44;
N, 9.95.
4.1.6. General synthetic procedure for Ig17
Compound Ie (1.68 g, 3 mmol) was dissolved in 20 mL anhydrous
tetrahydrofuran, and then PhI(AcO)2 (0.966 g, 3 mmol) and NH2CN
(0.139 g, 3.3 mmol) was added successively at 0 °C. After 5 min, the
solvent was evaporated and ethyl acetate (35 mL) was added. The
mixture was washed with sodium hydrogen sulfite (20 mL), and satu-
rated sodium chloride (20 mL) successively, and dried with anhydrous
sodium sulfate, and evaporated to obtain Ig. White solid, yield: 72.9%,
m.p. 164–165 °C. 1H NMR (400 MHz, DMSO‑d6) δ 10.35 (s, 1H, Ph-NH-
CO), 8.33 (d, J = 4.5 Hz, 1H, Ph-CO-NH), 7.73 (s, 1H, Ph-H), 7.71 (s,
2H, 2Ph-H), 7.54 (s, 1H, Ph-H), 7.51 (s, 1H, Pyrazole-H), 7.40 (d,
J = 1.9 Hz, 1H, Ph-H), 4.54 (d, J = 12.5 Hz, 1H, 1/2CH2S), 4.50 (d,
J = 12.4 Hz, 1H, 1/2CH2S), 2.80 (s, 3H, CH3S), 2.65 (d, J = 4.4 Hz, 3H,
NHCH3), 2.17 (s, 3H, Ph-CH3). 13C NMR (101 MHz, DMSO‑d6) δ
166.15, 162.01, 155.63, 141.44, 139.42, 138.75, 137.51, 135.90,
133.57, 131.48, 131.18, 130.91, 130.72, 130.02, 129.52, 128.90,
125.35, 121.37, 106.66, 52.07, 31.71, 26.09, 17.65. Anal. calcd for
4.1.9. General synthetic procedure for Ik16
Compound Ij (0.328 g, 0.5 mmol) was dissolved in 5 mL tetra-
hydrofuran, and then a solution of potassium carbonate (0.083 g,
0.6 mmol) in 5 mL water was added. The reaction was stirred for 2 h at
room temperature. Ethyl acetate (15 mL) was added, and washed with
saturated sodium chloride (15 mL). The organic layer was dried and
evaporated to obtain Ik. White solid, yield: 89.0%, m.p. 165–166 °C. 1H
NMR (400 MHz, DMSO‑d6) δ 10.36 (s, 1H, Ph-NH-CO), 8.35 (s, 1H, Ph-
CO-NH), 7.73 (s, 2H, Ph-H and Pyrazole-H), 7.66 (d, J = 8.0 Hz, 1H,
Ph-H), 7.59 (d, J = 7.6 Hz, 1H, Ph-H), 7.48 (s, 1H, Ph-H), 7.35 (s, 1H,
Ph-H), 4.45 (s, 2H, CH2S), 3.77 (s, 1H, S]NH), 2.73 (s, 3H, CH3S), 2.65
(s, 3H, NHCH3), 2.17 (s, 3H, Ph-CH3). 13C NMR (101 MHz, DMSO‑d6) δ
166.67, 156.15, 142.22, 139.91, 139.24, 137.53, 136.41, 133.95,
132.00, 131.66, 131.46, 131.41, 131.06, 130.44, 129.98, 125.84,
121.80, 107.10, 61.21, 40.87, 26.57, 18.13. Anal. calcd for
C
22H19Cl2F3N4O4S: C, 46.90; H, 3.40; N, 9.94; found: C, 46.94; H, 3.44;
N, 9.95.
C
22H20Cl2F3N5O3S: C, 46.98; H, 3.58; N, 12.45; found: C, 46.99; H,
4.1.7. General synthetic procedure for Ih
3.65; N, 12.49.
Compound Ig (0.285 g, 0.5 mmol) was dissolved in 10 mL anhy-
drous tetrahydrofuran, and then a solution of trifluoroacetic acid
(0.114 g, 1 mmol) in 5 mL tetrahydrofuran was added at 0 °C. The re-
action was stirred for 3 h at room temperature. The solvent was eva-
porated and ethyl acetate (20 mL) was added. The mixture was washed
with saturated sodium bicarbonate (15 mL), and saturated sodium
chloride (15 mL) successively, and dried with anhydrous sodium sul-
fate, and evaporated to obtain Ih. The synthetic procedure for Ij is si-
milar.
4.2. Biological assay
All biological assays were performed in a greenhouse. The bioassays
were replicated at each rate three times at 25
1 °C according to
statistical requirements. Assessments were made on a dead/alive basis
and corrected by applying Abbott’s formula.19 Evaluation was based on
a percentage scale of 0–100 (0 means no activity, and 100 means total
5%. LC50 values were calculated
Ih: White solid, yield: 75.8%, m.p. 157–158 °C. 1H NMR (400 MHz,
DMSO‑d6) δ 10.38 (s, 1H, Ph-NH-CO), 8.51 (d, J = 4.4 Hz, 1H, Ph-CO-
NH), 7.67 (s, 1H, Ph-H), 7.60 (s, 2H, 2Ph-H), 7.50 (s, 1H, Ph-H), 7.45 (s,
1H, Pyrazole-H), 7.41 (d, J = 1.7 Hz, 1H, Ph-H), 4.64 (d, J = 12.7 Hz,
1H, 1/2CH2S), 4.40 (d, J = 12.8 Hz, 1H, 1/2CH2S), 2.65 (s, 6H, NHCH3
and CH3S), 2.17 (s, 3H, Ph-CH3). 13C NMR (101 MHz, DMSO‑d6) δ
166.18, 165.03, 156.03, 141.02, 139.30, 139.15, 138.21, 135.80,
133.67, 132.47, 131.37, 131.20, 130.84, 130.37, 130.00, 129.47,
128.86, 125.24, 121.24, 106.51, 42.13, 30.01, 26.11, 17.43. Anal. calcd
for C23H19Cl2F3N6O3S: C, 47.03; H, 3.26; N, 14.31; found: C, 47.07; H,
3.28; N, 14.36.
4.2.1. Heart (dorsal vessel) rate against Periplaneta americana
The experiment was performed on adult males of the Periplaneta
americana according to the reported method.11
4.2.2. Larvicidal activity against oriental armyworm
The larvicidal activity of Ia-k and chlorantraniliprole against or-
iental armyworm was tested according to the leaf-dip method,21 and
the larvicidal activity is listed in Table 1.
Ij: White solid, yield: 86.4%, m.p. 147–148 °C. 1H NMR (400 MHz,
DMSO‑d6) δ 10.37 (s, 1H, Ph-NH-CO), 8.33 (s, 1H, Ph-CO-NH),
7.78–7.75 (d, J = 9.0 Hz, 3H, 2Ph-H and Pyrazole-H), 7.61 (s, 1H, Ph-
H), 7.49 (s, 1H, Ph-H), 7.35 (s, 1H, Ph-H), 5.18 (s, 2H, CH2S), 3.42 (s,
4.2.3. Larvicidal activity against diamondback moth
The larvicidal activity of Ia, Ib, Ie-j and chlorantraniliprole were
tested by the leaf-dip method,22 and the larvicidal activity is listed in
Table 2. LC50 values of If and chlorantraniliprole are listed in Table 3.
7